Intermittent Claudication Agents

Intermittent claudication agents comprise a therapeutic class of vasoactive and hemorheologic medications used to manage ischemic muscle pain and functional walking impairment resulting from peripheral artery disease The class primarily includes medications such as cilostazol, a phosphodiesterase-3 inhibitor that induces vasodilation and inhibits platelet aggregation, and pentoxifylline, a xanthine-derived rheologic agent that reduces blood viscosity and enhances erythrocyte deformability

Intermittent claudication agents comprise a therapeutic class of vasoactive and hemorheologic medications used to manage ischemic muscle pain and functional walking impairment resulting from peripheral artery disease By improving microvascular perfusion and lower-extremity blood flow without causing systemic hypotension, these agents primarily serve to increase pain-free and maximal walking distance in patients with chronic lower-extremity arterial occlusive disease

The class primarily includes medications such as cilostazol, a phosphodiesterase-3 inhibitor that induces vasodilation and inhibits platelet aggregation, and pentoxifylline, a xanthine-derived rheologic agent that reduces blood viscosity and enhances erythrocyte deformability

The class primarily includes medications such as cilostazol, a phosphodiesterase-3 inhibitor that induces vasodilation and inhibits platelet aggregation, and pentoxifylline, a xanthine-derived rheologic agent that reduces blood viscosity and enhances erythrocyte deformability

By improving microvascular perfusion and lower-extremity blood flow without causing systemic hypotension, these agents primarily serve to increase pain-free and maximal walking distance in patients with chronic lower-extremity arterial occlusive disease